Article info

Download PDFPDF
Infliximab efficacy and safety against refractory systemic necrotising vasculitides: long-term follow-up of 15 patients
  1. Professor L Guillevin, Department of Internal Medicine, Hôpital Cochin, 27, rue du Faubourg Saint-Jacques, 75679 Paris cedex 14, France; loic.guillevin{at}cch.aphp.fr
View Full Text

Citation

Josselin L, Mahr A, Cohen P, et al
Infliximab efficacy and safety against refractory systemic necrotising vasculitides: long-term follow-up of 15 patients

Publication history

  • Accepted April 9, 2008
  • First published April 29, 2008.
Online issue publication 
August 12, 2008

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.